Article
Apigenin-Melatonin: a novel prostate cancer Radiation Sensitizer
2023-01-05
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Radiotherapy is a common modality in prostate cancer (PrCa), with a dose of 80Gy. A higher dose of ionizing radiation is often needed to achieve an appropriate response; however, clinical evidence indicates that increasing the dose may lead to side effects. Therefore, finding a substance that sensitizes PrCa to ionizing radiation improves radiotherapy’s therapeu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 630f0e9f-16dc-5a58-bcca-f3b45ad44a86
- DOI
- 10.21203/rs.3.rs-2395901/v1
